Drug Profile
Research programme: gestational and type 2 diabetes diagnostics - Toronto Innovation Acceleration Partners/Johnson & Johnson/University of Toronto
Latest Information Update: 07 Oct 2020
Price :
$50
*
At a glance
- Originator University of Toronto
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Gestational diabetes; Type 2 diabetes mellitus
Most Recent Events
- 28 Feb 2019 No recent reports of development identified for research development in Gestational diabetes(Diagnosis) in Canada
- 28 Feb 2019 No recent reports of development identified for research development in Type-2-diabetes-mellitus(Diagnosis) in Canada
- 12 Jan 2015 Early research in Diagnostic tests in Canada (unspecified route)